CSL’s Response to COVID-19
Despite the constantly challenging environment the COVID-19 pandemic has presented to the world, CSL has remained steadfast in our promise to safeguarding our patients, our plasma donors and our employees. As the pandemic continues to evolve, so have we. CSL has redirected resources and taken on extra commitments to protect public health where we could offer the most value, including our expertise, technologies, equipment and materials. And through it all, we continue to deliver on our promise for those who need us most, our patients.Read More About CSL Behring's Efforts with COVID-19
CSL Scientist Strikes a Pose in Australian Vogue
A glossy magazine feature spotlights four women who played key roles in Australia’s COVID-19 vaccine development, including C…
Building Bikes for Kids
CSL Behring employees worked as a team to assemble – and test ride – bicycles for children in a Big Brothers, Big Sisters pro…
Accelerating Research in Europe
In partnership with university scientists, CSL fast-tracks four research programs.
Getting Ready for Rare Disease Day 2022
On February 28, the global community of rare disease advocates will share their colors. Get tips on how to make the most of i…
Can Talk Therapy Help Manage Pain?
Cognitive behavioral therapy can be a toolbox for dealing with chronic pain, some experts say.
Three Shots and a Booster for PI Patients
Even prior to the Omicron variant, U.S. experts urged four COVID-19 shots for this group after research found the vaccines pr…
The Spider Everyone Is Talking About
A funnel web “megaspider” recently made headlines in Australia and it just might save lives.